Lonza | LONN - Capital Ordinário





Capital Ordinário Alterar Data
Akzo Nobel EUR 171.41M 100K 2026-06
Alcon AG USD 487.4M 0 2026-06
Almirall EUR 214.79M 0 2025-12
AstraZeneca USD 1.55B 44K 2026-06
BASF EUR 884.32M 8.2M 2026-06
Bayer EUR 982.42M 0 2026-06
Beiersdorf EUR 218.92M 1.29M 2025-12
Covestro EUR 207.64M 18.9M 2025-12
Demant DKK 210.9M 5.18M 2025-12
Fresenius EUR 563.24M 0 2026-06
Fresenius Medical Care EUR 266.11M 3.98M 2026-06
Geberit CHF 32.97M 11.38K 2025-12
Genmab DKK 61.44M 181K 2026-06
Givaudan CHF 9.23M 0 2025-12
GlaxoSmithKline GBP 4.08B 20.6M 2026-06
GN Store Nord DKK 145.61M 0 2026-06
Hikma Pharmaceutical USD 221.89M 181.89M 2025-12
Johnson Matthey GBP 168.06M 0 2026-06
Merck EUR 434.78M 0 2026-06
Novartis USD 1.9B 7.38M 2026-06
Philips EUR 952.02M 729K 2026-03
Roche Holding CHF 796.77M 1.15M 2026-06
Sanofi EUR 1.21B 8.25M 2026-03
Sika AG CHF 160.44M 5.27K 2025-12
Smith & Nephew USD 875.95M 11.64K 2026-06
Solvay EUR 104.62M 145K 2026-06
UCB EUR 190.36M 365.15K 2025-12